A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials.
Berger MD, Ning Y, Stintzing S, Heinemann V, Cao S, Zhang W, Yang D, Miyamoto Y, Suenaga M, Schirripa M, Hanna DL, Soni S, Puccini A, Tokunaga R, Naseem M, Battaglin F, Cremolini C, Falcone A, Loupakis F, Lenz HJ.
Berger MD, et al. Among authors: puccini a.
Eur J Cancer. 2020 May;131:89-97. doi: 10.1016/j.ejca.2020.02.048. Epub 2020 Apr 16.
Eur J Cancer. 2020.
PMID: 32305727
Free PMC article.